Viewing StudyNCT06509971



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06509971
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-07

Brief Title: A Study of QL1706 an Anti-PD-1CTLA-4 Combined Antibody Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
Sponsor: None
Organization: None

Conditions & Keywords Data

Conditions:
Keywords: